Skip to main content

BRIDGE AD 2025: Workbook 2

Page 1

BUILDING BRIDGES TO BRING ANTIAMYLOID MONOCLONAL ANTIBODIES TO ELIGIBLE PATIENTS WITH ALZHEIMER’S DISEASE WORKSHOP 2

Overcoming Hurdles to Antiamyloid mAb Clinic Protocol Development

This activity is provided by Integritas Communications. This activity is supported by an educational grant from Eisai Inc.

For additional CME/CE opportunities, please visit www.ExchangeCME.com.


Turn static files into dynamic content formats.

Create a flipbook
BRIDGE AD 2025: Workbook 2 by Integritas Communications - Issuu